Zoledronic acid

Zoledronic acid
Zoledronic acid
Concentrate for solution for infusion, 4 mg/5 mL

Bone resorption inhibitor, bisphosphonate.

Instructions for medical use

Up-to-date information on medicinal products is available on the website of the Scientific Centre for Expert Evaluation of Medicinal Products or on the State Register of Medicines portal.

SCEEMP SRMP

An important complication of zoledronic acid therapy is osteonecrosis of the jaw. To ensure the correct use of medicinal products, patient information materials have been developed:

Privacy Policy

Terms of Use

Contact us

Report an adverse event

Websites

The information on this website is intended for healthcare professionals, representatives of medicinal product manufacturers, and representatives of pharmaceutical and medical companies.

This website is under the jurisdiction of the Russian Federation; accordingly, the information on this site is not intended for users from other countries whose legislation may require compliance with different rules regarding information, including its dissemination, collection, and processing. By continuing to use this website, you confirm that you are under the jurisdiction of the Russian Federation.